1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cystic fibrosis

OxyMask for delivering oxygen therapy

Medtech innovation briefing [MIB160] Published: 27 September 2018

  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Specialist commentator comments
  • Specialist commentators
  • Development of this briefing
Download (PDF)

Advice

  • Next

Regulatory information

Regulatory information

OxyMask is a CE marked class IIa medical device.


  • Next